Status and phase
Conditions
Treatments
About
Preeclampsia is one of the three leading causes of maternal morbidity and mortality all over the world. The use of low dose aspirin has been mentioned in several studies with promising results. The investigators decided to evaluate the use of low dose aspirin, starting between 13 and 16 weeks of pregnancy, based on clinical characteristics only to reduce the incidence of preeclampsia.
Enrollment
Sex
Volunteers
Inclusion criteria
Preeclampsia in a previous pregnancy Mother or sister that developed preeclampsia in a previous pregnancy Diabetes Mellitus (insulin dependant) Chronic Hypertension (with/without proteinuria) Body Mass Index > 32 Multiple pregnancy Lupus or other autoimmune disorder Chronic Renal Disease.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
476 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Osvaldo Reyes, MD; Rodrigo Velarde, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal